Frontal Fibrosing Alopecia

The cause of frontal fibrosing alopecia is inconclusive at present.  However, we do know that people with autoimmune conditions are more likely to suffer.

There is evidence that genetics is involved.

A stressful event, a sudden illness or contact with new products,  can ‘trigger’ the condition.

The scientific data available regarding LPP (Lichen Planuspolaris) which looks very similar to frontal fibrosing alopecia, also suggests that FFA is frequently associated with autoimmune conditions, particularly hypothyroidism.

A large number of patients with FFA have had metal amalgam or gold alloy dental implants placed in their gums, so patch testing may be done to confirm whether the patient has a contact allergy to any of these metals.

The use of sunscreen and products containing SPF's, have also been questioned as a possible cause of FFA.

Both men and women can be affected by frontal fibrosing alopecia, typically caucasian and over 45 years of age.

We are unsure at present why this affects these particular individuals.

However, there are four known gene markers that increase the risk of FFA. 

Frontal fibrosing alopecia (FFA)  predominantly affects Caucasian postmenopausal females.

When blood tests are analysed, there are low levels of testosterone, and these females are more likely to enter early menopause.

It is an inflammatory condition that men with autoimmune sensitivity are more susceptible to.

This condition can also cause the loss of hair on the frontal scalp (hairline), sideburns and eyebrows, as well as the body.

Environmental factors are also thought to contribute to this condition. However, studies are still being carried out. Please see the latest study here.

Whilst there is no absolute treatment at the moment, the condition can be treated and controlled with a combination of systemic and topical therapies such as  anti-malarial tablets or oral and topical steroids, if the case is rapid in nature.  In some patients FFA it can stabilise.

Generally, frontal fibrosing alopecia is slow to progress and in some cases stabilises over time.  However, no remedial therapy is available to reverse this condition.

Treatment for the condition once diagnosed would be to refer the patient to a dermatologist, where topical and intralesional steroids, such as, hydroxychloroquine and calcineurin inhibitors may be prescribed.

At TrichoSynergy, laser therapy has been effective in treating many patients.

Frontal Fibrosing Alopecia studies are ongoing as it is critical to continue to investigate its cause(s) and treatments to improve the long-term prognosis' of patients suffering from this type of scarring hair loss.

Early intervention is still considered the best way to reduce the impact of frontal fibrosing alopecia.

If this condition is worrying you please get in touch to see if we can be of assistance.